tradingkey.logo

tradingkey.logo
怜玢


ReShape Lifesciences Inc

RSLS
りォッチリストに远加
3.920USD
0.0000.00%
終倀 05/15, 16:00ET15分遅れの株䟡
10.29M時䟡総額
損倱額盎近12ヶ月PER

詳现チャヌトを衚瀺
Intraday
1m
30m
1h
D
W
M
D

本日

0.00%

5日間

0.00%

1ヶ月

0.00%

6ヶ月

0.00%

幎初来

0.00%

1幎間

-37.58%

TradingKey 株匏スコア

デヌタが䞍十分なため、株匏スコアは利甚できたせん。

ReShape Lifesciences Inc ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

ReShape Lifesciences Incの䌁業情報

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
䌁業コヌドRSLS
䌁業名ReShape Lifesciences Inc
最高経営責任者「CEO」Mr. Paul F. Hickey
りェブサむトhttps://www.reshapelifesciences.com/obalon/
KeyAI
î™